https://nova.newcastle.edu.au/vital/access/ /manager/Index ${session.getAttribute("locale")} 5 Assessing the concurrent validity, inter-rater reliability and test-re-test reliability of the Australian Treatment Outcomes Profile (ATOP) in alcohol and opioid treatment populations https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:49530 Tue 23 May 2023 12:12:21 AEST ]]> 96-week retention in treatment with extended-release subcutaneous buprenorphine depot injections among people with opioid dependence: Extended follow-up after a single-arm trial https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:55154 Tue 16 Apr 2024 15:25:19 AEST ]]> The impact of blood-borne viruses on cause-specific mortality among opioid dependent people: an Australian population-based cohort study https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:28914 Sat 24 Mar 2018 07:25:58 AEDT ]]> Outcomes of a single-arm implementation trial of extended-release subcutaneous buprenorphine depot injections in people with opioid dependence https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:46800 Mon 05 Dec 2022 08:29:28 AEDT ]]> Tracing the affordances of long-acting injectable depot buprenorphine: A qualitative study of patients’ experiences in Australia https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:49822 Fri 02 Jun 2023 16:30:17 AEST ]]>